FDA Clearance Tracker · P180035
MiSight 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear
Last checked: Nov 20, 2026Latest source record: Nov 15, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Nov 15, 2019
Approved
Time to decision
437 days
Received Sep 4, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P180035
- Device name
- MiSight 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear
- Applicant
- CooperVision, Inc.
- Applicant location
- Pleasanton, CA
- Received
- Sep 4, 2018
- Decided
- Nov 15, 2019
- Decision
- Approved
- Supplements
- 34 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for MiSight 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear. This device indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with less than or equal to 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QIT (Daily wear soft contact lens to reduce the progression of myopia).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for CooperVision, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K234127 · Decided Jan 25, 2024 · 28 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K220070 · Decided Feb 4, 2022 · 25 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
- Avaira Vitality510(k)
K213164 · Decided Oct 26, 2021 · 28 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.